Comparison of balloon-expandable vs self-expandable valves in patients undergoing transcatheter aortic valve replacement: The CHOICE randomized clinical trial

JAMA

Volumn 311, Issue 15, 2014, Pages 1503-1514

  Abdel Wahab, Mohamed ^a   Mehilli, Julinda ^b   Frerker, Christian ^c   Neumann, Franz Josef ^d   Kurz, Thomas ^e   Tölg, Ralph ^a   Zachow, Dirk ^f   Guerra, Elena ^g   Massberg, Steffen ^b   Schaf̈er, Ulrich ^c,h   El Mawardy, Mohamed ^a   Richardt, Gert ^a  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^c DEPARTMENT OF CARDIOLOGY   (Germany)

^d UNIVERSITY HEART CENTER FREIBURG BAD KROZINGEN   (Germany)

^e UNIVERSITY OF LÜBECK   (Germany)

^f Segeberger Kliniken   (Germany)

^g Intracoronary Stenting and Antithrombosis Research Center   (Germany)

^h UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; AORTA STENOSIS; AORTA VALVE PROSTHESIS; AORTA VALVE REGURGITATION; ARTICLE; ARTIFICIAL HEART PACEMAKER; BALLOON-EXPANDABLE VALVE; CARDIOVASCULAR MORTALITY; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; DEVICE EMBOLIZATION; DEVICE MALPOSITIONING; DEVICE SAFETY; DISEASE SEVERITY; FEMALE; FOLLOW UP; GERMANY; HEART VALVE PROSTHESIS; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL DEVICE COMPLICATION; MULTICENTER STUDY; MULTIDETECTOR COMPUTED TOMOGRAPHY; OUTCOME ASSESSMENT; POSTOPERATIVE HEMORRHAGE; PRIORITY JOURNAL; PRODUCT PARAMETERS; PROSTHESIS SIZE; RANDOMIZED CONTROLLED TRIAL; SELF-EXPANDABLE VALVE; TRANSCATHETER AORTIC VALVE IMPLANTATION; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; TRANSTHORACIC ECHOCARDIOGRAPHY; VASCULAR ACCESS;

AGED; AGED, 80 AND OVER; AORTIC VALVE; AORTIC VALVE STENOSIS; CARDIAC CATHETERIZATION; FEMALE; HEART VALVE PROSTHESIS IMPLANTATION; HEMORRHAGE; HUMANS; MALE; MIDDLE AGED; PROSTHESIS DESIGN; RISK; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 84898644090     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2014.3316     Document Type: Article

References (35)

1. Leon MB, Smith CR, Mack M, et al PARTNER Trial Investigators. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med. 2010;363(17):1597-1607.
2. Smith CR, Leon MB, Mack MJ, et al PARTNER Trial Investigators. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med. 2011;364(23):2187-2198.
3. Grube E, Schuler G, Buellesfeld L, et al. Percutaneous aortic valve replacement for severe aortic stenosis in high-risk patients using the second- and current third-generation self-expanding CoreValve prosthesis: device success and 30-day clinical outcome. J AmColl Cardiol. 2007;50(1):69-76. (Pubitemid 46970878)
4. Grube E, Buellesfeld L, Mueller R, et al. Progress and current status of percutaneous aortic valve replacement: results of three device generations of the CoreValve Revalving system. Circ Cardiovasc Interv. 2008;1(3):167-175.
5. Moat NE, Ludman P, de Belder MA, et al. Long-term outcomes after transcatheter aortic valve implantation in high-risk patients with severe aortic stenosis: the UK TAVI (United Kingdom Transcatheter Aortic Valve Implantation) Registry. J AmColl Cardiol. 2011;58(20):2130-2138.
6. Gilard M, Eltchaninoff H, Iung B, et al; FRANCE 2 Investigators. Registry of transcatheter aortic-valve implantation in high-risk patients. N Engl J Med. 2012;366(18):1705-1715.
7. Nombela-Franco L, Ruel M, Radhakrishnan S, et al. Comparison of hemodynamic performance of self-expandable CoreValve vs balloon-expandable Edwards SAPIEN aortic valves inserted by catheter for aortic stenosis. Am J Cardiol. 2013;111(7):1026-1033.
8. Abdel-Wahab M, Comberg T, Büttner HJ, et al Segeberg-Krozingen TAVI Registry. Aortic regurgitation after transcatheter aortic valve implantation with balloon- and self-expandable prostheses: a pooled analysis from a 2-center experience. JACC Cardiovasc Interv. 2014;7(3):284-292.
9. Abdel-Wahab M, Zahn R, Horack M, et al German Transcatheter Aortic Valve Interventions Registry Investigators. Aortic regurgitation after transcatheter aortic valve implantation: incidence and early outcome: results from the German transcatheter aortic valve interventions registry. Heart. 2011;97(11):899-906.
10. Tamburino C, Capodanno D, Ramondo A, et al. Incidence and predictors of early and late mortality after transcatheter aortic valve implantation in 663 patients with severe aortic stenosis. Circulation. 2011;123(3):299-308.
11. Kodali SK, Williams MR, Smith CR, et al PARTNER Trial Investigators. Two-year outcomes after transcatheter or surgical aortic-valve replacement. N Engl J Med. 2012;366(18):1686-1695.
12. Willson AB,Webb JG, Labounty TM, et al. 3-dimensional aortic annular assessment by multidetector computed tomography predicts moderate or severe paravalvular regurgitation after transcatheter aortic valve replacement: a multicenter retrospective analysis. J AmColl Cardiol. 2012;59(14):1287-1294.
13. Tops LF,Wood DA, Delgado V, et al. Noninvasive evaluation of the aortic root with multislice computed tomography implications for transcatheter aortic valve replacement. JACC Cardiovasc Imaging. 2008;1(3):321-330. (Pubitemid 351681425)
14. BarbantiM, Yang TH, Rodès Cabau J, et al. Anatomical and procedural features associated with aortic root rupture during balloon-expandable transcatheter aortic valve replacement. Circulation. 2013;128(3):244-253.
15. Vahanian A, Alfieri O, Al-Attar N, et al European Association of Cardio-Thoracic Surgery; European Society of Cardiology; European Association of Percutaneous Cardiovascular Interventions. Transcatheter valve implantation for patients with aortic stenosis: a position statement from the European Association of Cardio-Thoracic Surgery (EACTS) and the European Society of Cardiology (ESC), in collaboration with the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur Heart J. 2008;29(11):1463-1470. (Pubitemid 351806497)
16. Kasel AM, Cassese S, Bleiziffer S, et al. Standardized imaging for aortic annular sizing: implications for transcatheter valve selection. JACC Cardiovasc Imaging. 2013;6(2):249-262.
17. Willson AB,Webb JG, Freeman M, et al. Computed tomography-based sizing recommendations for transcatheter aortic valve replacement with balloon-expandable valves: comparison with transesophageal echocardiography and rationale for implementation in a prospective trial. J Cardiovasc Comput Tomogr. 2012;6(6):406-414.
18. Webb JG, Altwegg L, Boone RH, et al. Transcatheter aortic valve implantation: impact on clinical and valve-related outcomes. Circulation. 2009;119(23):3009-3016.
19. Sellers RD, LevyMJ, Amplatz K, Lillehei CW. Left retrograde cardioangiography in acquired cardiac disease: technic, indications and interpretations in 700 cases. Am J Cardiol. 1964;14:437-447.
20. Leon MB, Piazza N, Nikolsky E, et al. Standardized endpoint definitions for transcatheter aortic valve implantation clinical trials: a consensus report from the Valve Academic Research Consortium. Eur Heart J. 2011;32(2):205-217.
21. ZoghbiWA, Chambers JB, Dumesnil JG, et al American Society of Echocardiography's Guidelines and Standards Committee; Task Force on Prosthetic Valves; American College of Cardiology Cardiovascular Imaging Committee; Cardiac Imaging Committee of the American Heart Association; European Association of Echocardiography; European Society of Cardiology; Japanese Society of Echocardiography; Canadian Society of Echocardiography; American College of Cardiology Foundation; American Heart Association; European Association of Echocardiography; European Society of Cardiology; Japanese Society of Echocardiography; Canadian Society of Echocardiography. Recommendations for evaluation of prosthetic valves with echocardiography and Doppler ultrasound. J Am Soc Echocardiogr. 2009;22(9):975-1014.
22. Sinning JM, Hammerstingl C, Vasa-Nicotera M, et al. Aortic regurgitation index defines severity of peri-prosthetic regurgitation and predicts outcome in patients after transcatheter aortic valve implantation. J AmColl Cardiol. 2012;59(13):1134-1141.
23. Merten C, Beurich HW, Zachow D, et al. Aortic regurgitation and left ventricular remodeling after transcatheter aortic valve implantation: a serial cardiac magnetic resonance imaging study. Circ Cardiovasc Interv. 2013;6(4):476-483.
24. Sherif MA, Abdel-Wahab M, Beurich HW, et al. Haemodynamic evaluation of aortic regurgitation after transcatheter aortic valve implantation using cardiovascular magnetic resonance. EuroIntervention. 2011;7(1):57-63.
25. Rabin R, de Charro F. EQ-5D: a measure of health status from the EuroQol Group. Ann Med. 2001;33(5):337-343. (Pubitemid 32675374)
26. Chieffo A, Buchanan GL, Van Mieghem NM, et al. Transcatheter aortic valve implantation with the Edwards SAPIEN versus the Medtronic CoreValve Revalving system devices: a multicenter collaborative study: the PRAGMATIC Plus Initiative (Pooled-RotterdAm-Milano-Toulouse In Collaboration). J AmColl Cardiol. 2013;61(8):830-836.
27. Unbehaun A, PasicM, Dreysse S, et al. Transapical aortic valve implantation: incidence and predictors of paravalvular leakage and transvalvular regurgitation in a series of 358 patients. J AmColl Cardiol. 2012;59(3):211-221.
28. Athappan G, Patvardhan E, Tuzcu EM, et al. Incidence, predictors, and outcomes of aortic regurgitation after transcatheter aortic valve replacement:meta-analysis and systematic review of literature. J AmColl Cardiol. 2013;61(15):1585-1595.
29. Tchetche D, Modine T, Farah B, et al. Update on the need for a permanent pacemaker after transcatheter aortic valve implantation using the CoreValve Accutrak system. EuroIntervention. 2012;8(5):556-562.
30. Popma JJ. CoreValve US Pivotal Trial Extreme Risk Iliofemoral Study Results. Presented at Transcatheter Cardiovascular Therapeutics; October 2013; San Francisco, CA.
31. Zegdi R, Lecuyer L, Achouh P, et al. Increased radial force improves stent deployment in tricuspid but not in bicuspid stenotic native aortic valves. Ann Thorac Surg. 2010;89(3):768-772.
32. Tzamtzis S, Viquerat J, Yap J, MullenMJ, Burriesci G. Numerical analysis of the radial force produced by the Medtronic-CoreValve and Edwards-SAPIEN after transcatheter aortic valve implantation (TAVI). Med Eng Phys. 2013;35(1):125-130.
33. Makkar RR, Jilaihawi H, Chakravarty T, et al. Determinants and outcomes of acute transcatheter valve-in-valve therapy or embolization: a study of multiple valve implants in the US PARTNER trial (Placement of AoRTic TraNscathetER Valve Trial Edwards SAPIEN Transcatheter Heart Valve). J Am Coll Cardiol. 2013;62(5):418-430.
34. Piazza N, Martucci G, Lachapelle K, et al First-in-human experience with the Medtronic CoreValve Evolut R [published online December 13, 2013]. Eurointervention. doi:10.4244/EIJV9I11A215.
35. Généreux P, Head SJ, Hahn R, et al. Paravalvular leak after transcatheter aortic valve replacement: the new Achilles' heel? a comprehensive review of the literature. J AmColl Cardiol. 2013;61(11):1125-1136.